Similar articles

• Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010.

  Centers for Disease Control and Prevention (CDC). Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2010 Jun 4;59(21):657-61. MMWR Morb Mortal Wkly Rep. 2010. PMID: 20520590
• Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis.

  Salmon DA, Proschan M, Forshee R, Gargiullo P, Bleser W, Burwen DR, Cunningham F, Garman P, Greene SK, Lee GM, Vellozzi C, Yih WK, Gellin B, Lurie N; H1N1 GBS Meta-Analysis Working Group. Salmon DA, et al. Lancet. 2013 Apr 27;381(9876):1461-8. doi: 10.1016/S0140-6736(12)62189-8. Epub 2013 Mar 13. Lancet. 2013. PMID: 23498095
• Safety and effectiveness of a 2009 H1N1 vaccine in Beijing.

  Wu J, Xu F, Lu L, Lu M, Miao L, Gao T, Ji W, Suo L, Liu D, Ma R, Yu R, Zhangzhu J, Liu W, Zeng Y, Li X, Zhang X, Pang X, Deng Y. Wu J, et al. N Engl J Med. 2010 Dec 16;363(25):2416-23. doi: 10.1056/NEJMoa1006736. N Engl J Med. 2010. PMID: 21158658
• [Vaccination against influenza and Guillain-Barre syndrome: are there any relations?].

  Wiercińska-Drapało A, Grzeszczuk A, Wasilewski K, Prokopowicz D. Wiercińska-Drapało A, et al. Pol Merkur Lekarski. 2000 May;8(47):360-1. Pol Merkur Lekarski. 2000. PMID: 10944963 Review. Polish.
• [Evidence of indications of influenza vaccine and its efficacy--including Guillain-Barré syndrome as an adverse reaction(?)].

  Watanabe A. Watanabe A. Nihon Rinsho. 2003 Nov;61(11):1987-91. Nihon Rinsho. 2003. PMID: 14619443 Review. Japanese.